How much can I invest?

With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors. With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000 are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, they are limited to investing 10% of the greater of the two amounts.

How to open a Self-Directed IRA on StartEngine?

StartEngine makes it easy to invest using your retirement funds. You can open a self-directed IRA account through StartEngine. To get started, simply visit our IRA page for more information and step-by-step instructions. Already have a self-directed IRA with another provider? You can still invest on StartEngine, but please note that the process will be manual and may take longer to complete.

When will I receive my shares?

At the close of an offering, all investors whose funds have cleared by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward. Please keep in mind that a company can conduct a series of closes or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.

What will the return on my investment be?

StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.

Can I cancel my investment?

For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as Invested on your account dashboard, your investment can no longer be canceled. For Regulation A+, StartEngine allows for a four-hour cancellation period. Once the four-hour window has passed, it is up to each company to set their own cancellation policy. You may find the company’s cancellation policy in the company’s offering circular. Once your investment is canceled, there is a 10-day clearing period from the date your investment was submitted. After your funds have cleared the bank, you will receive your refund within 10 business days. Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to be sent back to the account associated with the investment.

What is the difference between Regulation Crowdfunding and Regulation A+?

Both Title III Regulation Crowdfunding and Title IV Regulation A+ help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, learn about Regulation Crowdfunding, and for Regulation A+, learn about Regulation A+.

StartEngine

Loading investment details

Loading offering details…

StartEngine

Loading investments…

Invest in AllerGenis (2023 Round) | StartEngine

AllerGenis

Allergenis provides the next generation of food allergy testing using cutting-edge systems biology and data analytics to accurately determine allergic status, tolerance levels, and reaction severity for a more informed quality of life when living with a diagnosis of food allergy. Additionally, Allergenis is the first food allergy test that can be initiated by a caregiver and/or individual via a partner telemedicine channel, all while receiving the necessary medical support from an allergist with expertise in managing food allergies. We currently provide peanut allergic status and threshold testing in 49 states, and Washington DC, with milk allergy testing launching later this year, and egg allergy testing in 2024.

The Next Generation of Food Allergy Testing

What is AllerGenis?: Allergenis provides the next generation of food allergy testing using cutting-edge systems biology and data analytics to accurately determine allergic status, tolerance levels, and reaction severity for a more informed quality of life when living with a diagnosis of food allergy. Additionally, Allergenis is the first food allergy test that can be initiated by a caregiver and/or individual via a partner telemedicine channel, all while receiving the necessary medical support from an allergist with expertise in managing food allergies.
How much can I invest?: With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors. With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000 are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, they are limited to investing 10% of the greater of the two amounts.
How to open a Self-Directed IRA on StartEngine?: StartEngine makes it easy to invest using your retirement funds. You can open a self-directed IRA account through StartEngine. To get started, simply visit our IRA page for more information and step-by-step instructions. Already have a self-directed IRA with another provider? You can still invest on StartEngine, but please note that the process will be manual and may take longer to complete.
When will I receive my shares?: At the close of an offering, all investors whose funds have cleared by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward. Please keep in mind that a company can conduct a series of closes or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.

Offering Closed

INVEST IN ALLERGENIS · HEALTH TECH

The Next Generation of Food Allergy Testing

Offering Closed

This Reg CF offering is made available through StartEngine Capital, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

StartEngine

AllerGenis

Loading offering details…

AllerGenis

The Next Generation of Food Allergy Testing

What is AllerGenis?: Allergenis provides the next generation of food allergy testing using cutting-edge systems biology and data analytics to accurately determine allergic status, tolerance levels, and reaction severity for a more informed quality of life when living with a diagnosis of food allergy. Additionally, Allergenis is the first food allergy test that can be initiated by a caregiver and/or individual via a partner telemedicine channel, all while receiving the necessary medical support from an allergist with expertise in managing food allergies.
How much can I invest?: With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors. With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000 are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, they are limited to investing 10% of the greater of the two amounts.
How to open a Self-Directed IRA on StartEngine?: StartEngine makes it easy to invest using your retirement funds. You can open a self-directed IRA account through StartEngine. To get started, simply visit our IRA page for more information and step-by-step instructions. Already have a self-directed IRA with another provider? You can still invest on StartEngine, but please note that the process will be manual and may take longer to complete.
When will I receive my shares?: At the close of an offering, all investors whose funds have cleared by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward. Please keep in mind that a company can conduct a series of closes or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.

Offering Closed

INVEST IN ALLERGENIS · HEALTH TECH

The Next Generation of Food Allergy Testing

Offering Closed

REASONS TO INVEST

ABOUT

HEADQUARTERS

TERMS

AllerGenis

Overview

PRICE PER SHARE

$5

DEADLINE

Aug. 22, 2023 at 6:59 AM UTC

VALUATION

$40M

FUNDING GOAL

$10K - $1.24M

Breakdown

MIN INVESTMENT

$250

MAX INVESTMENT

$1,235,000

MIN NUMBER OF SHARES OFFERED

2,000

MAX NUMBER OF SHARES OFFERED

247,000

OFFERING TYPE

Equity

SHARES OFFERED

Non-Voting Common Stock

Maximum Number of Shares Offered subject to adjustment for bonus shares

Most Recent Fiscal Year-End

Prior Fiscal Year-End

Total Assets

$454,522

$368,099

Cash & Cash Equivalents

$31,203

$19,639

Accounts Receivable

$4,395

$10,000

Short-Term Debt

$5,157,434

$1,496,119

Long-Term Debt

$1,050,000

$2,942,000

Revenue & Sales

$74,140

$269,597

Costs of Goods Sold

Taxes Paid

Net Income

-$4,952,594

-$3,422,933

Risks

A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.

*The Offering Maximum Non-Voting Common Stock subject to adjustment for bonus shares. See “Investment Incentives and Bonuses.”

Voting Rights of Securities Sold in this Offering

Pursuant to the Subscription Agreement, investors agree to appoint the CEO, or his or her successor, as the investor’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to, consistent with the Subscription Agreement and on behalf of the investor, (i) vote all Securities held of record by the investor (including any shares of the Company’s capital stock that the investor may acquire in the future), (ii) give and receive notices and communications, (iii) execute any instrument or document that the CEO determines is necessary or appropriate in the exercise of its authority under this instrument at its own discretion, and (iv) take all actions necessary or appropriate in the judgment of the CEO for the accomplishment of the foregoing. The proxy and power granted by the investor are coupled with an interest. Such proxy and power will be irrevocable. The proxy and power, so long as the investor is an individual, will survive the death, incompetency and disability of the investor and, so long as the investor is an entity, will survive the merger or reorganization of the investor or any other entity holding the Securities. Such proxy shall be binding upon the heirs, estate, executors, personal representatives, successors and assigns of the investor (including any transferee of any Securities held by investor); any transferee receiving the investor’s Securities (or any portion thereof) shall agree to be bound by the proxy as set forth in the Subscription Agreement. However, the proxy will terminate upon the closing of a firm commitment underwritten public offering pursuant to an effective registration statement under the Securities Act covering the offer and sale of common stock or the effectiveness of a registration statement under the Securities Exchange Act covering the common stock.

Investment Incentives and Bonuses¹

Time-Based:

Friends and Family

Invest within 72 hours and receive 10% bonus shares and a Food Allergy Care Kit.

Early Bird Bonus

Invest within two weeks and receive 5% bonus shares.

Comb/Avid Investor

Invest $10,000+ within the first 48 hours and receive 20% bonus shares.

Amount-Based:

Tier 1 | Premier

Invest $1,000+ and receive a Food Allergy Care Kit.

Tier 2 | Silver

Invest $2,000+ and receive a Rebate Coupon* and a Food Allergy Care Kit.

Tier 3 | Gold

Invest $10,000+ and receive a Rebate Coupon, a Food Allergy Care Kit, 30-minute Zoom with CEO, Scientific & Medical Advisory Webinar, and 5% bonus shares.

Tier 4 | Diamond

Invest $25,000+ and receive a Rebate Coupon, Allergy Care Kit, 30-minute Zoom with CEO, Scientific & Medical Advisory Webinar, and 10% bonus shares.

Tier 5 | Platinum

Invest $100,000 + and receive a Rebate Coupon, a Food Allergy Care Kit, 30-minute Zoom with CEO, Advisory Webinar, and 15% bonus shares.

*Rebate Coupon valid for one Allergenis commercially available test (one food allergen) for one year from issue date and is fully transferable. Individual utilizing coupon must be eligible for testing.

The Allergy Care Kit is valued at approximately $60. Components may include but not guaranteed: water bottle, snack safe stickers, sample allergy guide, restaurant cards, red sneakers for Oakley keychain, food allergy book, and others.

30 Minute Zoom includes a 1:1 session with Allergenis CEO, Jim Garner.

The Scientific & Medical Advisory Webinar includes a 60-minute session with a member of our medical and/or development team.

¹In order to receive incentives and bonuses from an investment, you must submit a single investment in the same offering that meets the minimum incentive or bonus requirement. Bonus shares from perks will not be granted if you submit multiple investments that, when combined, meet the incentive or bonus requirement. All incentives and bonuses will occur when the Offering is completed.

The 10% StartEngine Owners' Bonus

AllerGenis will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Non-Voting Common Stock at $5.00/ share, you will receive 110 shares of Non-Voting Common Stock, meaning you'll own 110 shares for $5. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investor's eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.

Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and the time of offering elapsed (if any). Eligible investors will also receive the Owner’s Bonus and the aforementioned bonus.

Irregular Use of Proceeds

We will not incur any irregular use of proceeds.